A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
| Autor: | Yosuke Miura, Koichi Yamaguchi, Toshitaka Maeno, Kenichiro Hara, Takeshi Hisada, Ikuo Wakamatsu, Shogo Uno, Hiroaki Tsurumaki, Haruka Saito, Keiju Hiromura, Yuko Oishi, Norimitsu Kasahara, Yuri Sawada, Masakiyo Yatomi, Noriaki Sunaga, Chiharu Hanazato, Hidekazu Ikeuchi, Yasuhiko Koga |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Neurofibromatosis type I
medicine.medical_specialty neurofibromatosis business.industry Pleural effusion pneumothorax eosinophilic pleural effusion R895-920 computed tomography (CT) respiratory system medicine.disease Article Surgery respiratory tract diseases Coronavirus disease 2019 (COVID-19) Pneumonia Medical physics. Medical radiology. Nuclear medicine Pneumothorax Fibrosis Pulmonary fibrosis Eosinophilic medicine Radiology Nuclear Medicine and imaging Neurofibromatosis business |
| Zdroj: | Radiology Case Reports Radiology Case Reports, Vol 16, Iss 11, Pp 3504-3508 (2021) |
| ISSN: | 1930-0433 |
| Popis: | Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and evaluation of COVID-19 pneumonia and its complications. We encountered a case of a male patient with neurofibromatosis (type I) who developed concurrent pneumothorax and pleural effusion during his recovery period from severe COVID-19 pneumonia. Pulmonary fibrosis and emphysema were also confirmed. Furthermore, an eosinophil pleural effusion appeared and was prolonged during the healing process of COVID-19. This clinical presentation suggests that fibrosis and emphysema formation due to neurofibromatosis may have caused pneumothorax and pleural effusion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|